{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:14:30Z","timestamp":1698664470772},"reference-count":15,"publisher":"ALUNA","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:p>Aim: Our study aimed to present diagnostic problems in the case of hypercortisolism, pheochromocytoma, hypertension, type 2 diabetes, and chronic kidney disease. \nMaterials and Methods: Description of a patient with resistant hypertension admitted to the Department of Endocrinology for hormonal diagnostics. The results of hormonal tests and imaging tests before the procedure were analyzed, and the patient\u2019s condition was checked after the procedure. The analysis was extended with a literature review, considering the diagnostic problems in the described case. Electronic databases were the primary way to search, mainly MEDLINE and PubMed. We described a case of a 61-year-old woman diagnosed with right adrenal pheochromocytoma, hypercortisolemia, chronic kidney disease, drug-resistant hypertension, type 2 diabetes, and hypercholesterolemia. During hospitalization in the Department of Endocrinology, i.a., imaging tests and tests to assess adrenal function were performed. During the diagnostic process, a decision was made to perform surgical treatment of the pheochromocytoma, resulting in clinical improvement of the patient\u2019s condition. \nConclusions: The described case presents diagnostic problems endocrinologists face in the coexistence of several diseases. Often, the diagnosis to make a final diagnosis is complicated, hindered by the patient\u2019s multi-morbidity, as well as by the medications taken. There are few studies analyzing the coexistence of the diseases as described by us and their impact on the results of diagnostic tests that would facilitate the diagnosis.<\/jats:p>","DOI":"10.36740\/merkur202304118","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T17:26:28Z","timestamp":1695749188000},"page":"423-429","source":"Crossref","is-referenced-by-count":0,"title":["COEXISTENCE OF PHEOCHROMOCYTOMA AND HYPERCORTISOLEMIA. DIAGNOSTIC DIFFICULTIES"],"prefix":"10.36740","volume":"51","author":[{"given":"Monika","family":"Krzemi\u0144ska","sequence":"first","affiliation":[{"name":"STUDENT RESEARCH GROUP AT THE CHAIR AND DEPARTMENT OF PATHOPHYSIOLOGY AND ENDOCRINOLOGY FACULTY OF MEDICAL SCIENCES IN ZABRZE, MEDICAL UNIVERSITY OF SILESIA IN KATOWICE, ZABRZE, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Kruzel-Piszczek","sequence":"additional","affiliation":[{"name":"STUDENT RESEARCH GROUP AT THE CHAIR AND DEPARTMENT OF PATHOPHYSIOLOGY AND ENDOCRINOLOGY FACULTY OF MEDICAL SCIENCES IN ZABRZE, MEDICAL UNIVERSITY OF SILESIA IN KATOWICE, ZABRZE, POLAND"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22436","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref0","unstructured":"1. Januszewicz A, Prejbisz A, Dobrowolski P. Nadci\u015bnienie t\u0119tnicze pierwotne. In: Gajewski P (ed.). Interna Szczeklika. Medycyna Praktyczna, Krak\u00f3w, 2020, pp. 439-454."},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Samsel R, Papierska L, Nowak K, et al. Adrenal \u201cnonadenoma\u201d \u2013 clinical characteristics and risk of malignancy. Endokrynol Pol. 2021;72(5):492-497. doi:10.5603\/EP.a2021.0063.","DOI":"10.5603\/ep.a2021.0063"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Ja\u017cd\u017cewska K, Grych K, Obo\u0142o\u0144czyk \u0141, et al. Pseudopheochromocytoma \u2013 an epidemic of the modern world? Case series and review of literature. Arterial Hypertension 2023;27(1):56-62. doi: 10.5603\/AH.a2023.0005.","DOI":"10.5603\/ah.a2023.0005"},{"key":"ref3","unstructured":"4. Januszewicz W, Januszewicz A, Prejbisz A. Guz chromoch\u0142onny i przyzwojaki, In: Gajewski P (ed.). Interna Szczeklika. Medycyna Praktyczna, Krak\u00f3w, 2020, pp. 1459-1462."},{"key":"ref4","unstructured":"5. Bednarczuk D, Kasperlik-Za\u0142uska A, S\u0142owi\u0144ska-Srzednicka J.: Choroby przebiegaj\u0105ce z nadmiarem glikokortykosteroid\u00f3w (zesp\u00f3\u0142 Cushinga) In: Gajewski P (ed.). Interna Szczeklika. Medycyna Praktyczna, Krak\u00f3w, 2020, pp. 1438-1441."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Scaroni C, Albiger NM, Palmieri S, et al. Approach to patients with pseudo-Cushing\u2019s states. Endocrine Connections. 2020;9(1):1-13. doi: 10.1530\/EC-19-0435.","DOI":"10.1530\/ec-19-0435"},{"key":"ref6","unstructured":"7. Kajor M, Ziaja J, Lange D, et al. Analysis of morphology of adrenal pheochromocytoma as regards their potential malignancy. Endokrynol Pol. 2005;56(6):911-915."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. Bednarczuk T, Bolanowski M, Sworczak K, et. al. Adrenal incidentaloma in adults \u2013 management recommendations by the Polish Society of Endocrinology. Endokrynol Pol. 2016; 67(2):234-258. doi: 10.5603\/EP.a2016.0039.","DOI":"10.5603\/EP.a2016.0039"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Valassi E, Swearingen B, Lee H, et al. Concomitant Medication Use Can Confound Interpretation of the Combined Dexamethasone-Corticotropin Releasing Hormone Test in Cushing\u2019s Syndrome. J Clin Endocrinol Metab. 2009;94(12):4851-4859. doi: 10.1210\/jc.2009-1500.","DOI":"10.1210\/jc.2009-1500"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Sobolewska J, \u017bak Z, Monia-Tutur K, et al. Endocrine disorders in chronic kidney disease. Paediatr Fam Med. 2022;18(3):209-218. doi: 10.15557\/PiMR.2022.0031.","DOI":"10.15557\/PiMR.2022.0031"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Raff H., Trivedi H.: Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease. Endocr Connect. 2013; 2(1); 23-31. doi: 10.1530\/EC-12-0058.","DOI":"10.1530\/ec-12-0058"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Huang W, Molitch ME. Prolactin and Other Pituitary Disorders in Kidney Disease. Semin Nephrol. 2021;41(2):156-167. doi: 10.1016\/j.semnephrol.2021.03.010.","DOI":"10.1016\/j.semnephrol.2021.03.010"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Nieman LK, Biller BMK, Findling JW, et al. The Diagnosis of Cushing\u2019s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. doi: 10.1210\/jc.2008-0125.","DOI":"10.1210\/jc.2008-0125"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Gungunes A, Sahin M, Demirci T, et al. Cushing\u2019s syndrome in type 2 diabetes patients with poor glycemic control. Endocrine 2014;47(3):895-900. doi: 10.1007\/s12020-014-0260-8.","DOI":"10.1007\/s12020-014-0260-8"},{"key":"ref14","unstructured":"15. Ignaszak-Szczepaniak M., Horst-Sikorska W. Incidentaloma nadnerczy - czy obawia\u0107 si\u0119 rozpoznania? Forum Med Rodz. 2007;1(4);384-391."}],"container-title":["Polski Merkuriusz Lekarski"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:08:56Z","timestamp":1698599336000},"score":1,"resource":{"primary":{"URL":"https:\/\/polskimerkuriuszlekarski.pl\/wp-content\/uploads\/library\/PolMerkurLek2023i4.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023]]},"published-print":{"date-parts":[[2023,8]]}},"URL":"https:\/\/doi.org\/10.36740\/merkur202304118","archive":["Internet Archive"],"relation":{},"ISSN":["1426-9686"],"issn-type":[{"value":"1426-9686","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}